TRANSDERMAL AND/OR TOPICAL DELIVERY SYSTEMS COMPOSED OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE IN COMBINATION, OR ALONE

USPTO Patent Application US 2017/0049759 A1
Application Date: Feb. 23rd, 2017

ABSTRACT

Pharmaceutical compositions for simultaneous transdermal delivery of Doxylamine and Pyridoxine comprising Doxylamine or its salts, Pyridoxine or its salts or its active metabolites and a vehicle system wherein pharmaceutical compositions...
Application Number:
15/228,382
International Classification:
A61K 31/4415 (20060101); A61K 31/4402 (20060101); A61K 9/06 (20060101); A61K 9/00 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1. A transdermal pharmaceutical composition in a liquid formulation comprising: A first active agent selected from the group consisting of Doxylamine free base, a pharmaceutically acceptable salt of Doxylamine, and combinations thereof;A second active agent selected from the group consisting of Pyridoxine free base, a pharmaceutically acceptable salt of Pyridoxine, active...

DESCRIPTION

This application claims benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 62/205,941, filed Aug. 17, 2015, the contents of which are incorporated in their entirety herein.
Back to Top